These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 22978440)

  • 21. Metformin and thiazolidinedione use in Medicare patients with heart failure.
    Masoudi FA; Wang Y; Inzucchi SE; Setaro JF; Havranek EP; Foody JM; Krumholz HM
    JAMA; 2003 Jul; 290(1):81-5. PubMed ID: 12837715
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Comparative cost-effectiveness of metformin-based dual therapies associated with risk of cardiovascular diseases among Chinese patients with type 2 diabetes: Evidence from a population-based national cohort in Taiwan.
    Ou HT; Chen YT; Liu YM; Wu JS
    Diabetes Res Clin Pract; 2016 Jun; 116():14-25. PubMed ID: 27321311
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Comparative risk of major cardiovascular events associated with second-line antidiabetic treatments: a retrospective cohort study using UK primary care data linked to hospitalization and mortality records.
    Zghebi SS; Steinke DT; Rutter MK; Emsley RA; Ashcroft DM
    Diabetes Obes Metab; 2016 Sep; 18(9):916-24. PubMed ID: 27177784
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Risk of overall mortality and cardiovascular events in patients with type 2 diabetes on dual drug therapy including metformin: A large database study from the Cleveland Clinic.
    Kannan S; Pantalone KM; Matsuda S; Wells BJ; Karafa M; Zimmerman RS
    J Diabetes; 2016 Mar; 8(2):279-85. PubMed ID: 25929426
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Treatment with metformin is associated with higher remission rate in diabetic patients with thyroid cancer.
    Klubo-Gwiezdzinska J; Costello J; Patel A; Bauer A; Jensen K; Mete M; Burman KD; Wartofsky L; Vasko V
    J Clin Endocrinol Metab; 2013 Aug; 98(8):3269-79. PubMed ID: 23709654
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The Effect of Metformin Use during Docetaxel Chemotherapy on Prostate Cancer Specific and Overall Survival of Diabetic Patients with Castration Resistant Prostate Cancer.
    Mayer MJ; Klotz LH; Venkateswaran V
    J Urol; 2017 Apr; 197(4):1068-1075. PubMed ID: 27984108
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Diabetes mellitus without metformin intake is associated with worse oncologic outcomes after radical nephroureterectomy for upper tract urothelial carcinoma.
    Rieken M; Xylinas E; Kluth L; Trinh QD; Lee RK; Fajkovic H; Novara G; Margulis V; Lotan Y; Martinez-Salamanca JI; Matsumoto K; Seitz C; Remzi M; Karakiewicz PI; Scherr DS; Briganti A; Kautzky-Willer A; Bachmann A; Shariat SF;
    Eur J Surg Oncol; 2014 Jan; 40(1):113-20. PubMed ID: 24113620
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Comparative efficacy and safety of antidiabetic drug regimens added to stable and inadequate metformin and thiazolidinedione therapy in type 2 diabetes.
    Saulsberry WJ; Coleman CI; Mearns ES; Zaccaro E; Doleh Y; Sobieraj DM
    Int J Clin Pract; 2015 Nov; 69(11):1221-35. PubMed ID: 26215321
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Thiazolidinedione use and atrial fibrillation in diabetic patients: a meta-analysis.
    Zhang Z; Zhang X; Korantzopoulos P; Letsas KP; Tse G; Gong M; Meng L; Li G; Liu T
    BMC Cardiovasc Disord; 2017 Apr; 17(1):96. PubMed ID: 28381265
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Antidiabetic drug use and prostate cancer risk in the Finnish Randomized Study of Screening for Prostate Cancer.
    Haring A; Murtola TJ; Talala K; Taari K; Tammela TL; Auvinen A
    Scand J Urol; 2017 Feb; 51(1):5-12. PubMed ID: 28084175
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Impact of diabetes and metformin use on prostate cancer outcome of patients treated with radiation therapy: results from a large institutional database.
    Taussky D; Preisser F; Karakiewicz PI; Tilki D; Lambert C; Bahary JP; Delouya G; Wistaff R; Laskine M; Nguyen PV; Durand M; Saad F
    Can J Urol; 2018 Oct; 25(5):9509-9515. PubMed ID: 30281009
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The risk of coronary heart disease in type 2 diabetic patients exposed to thiazolidinediones compared to metformin and sulfonylurea therapy.
    Johannes CB; Koro CE; Quinn SG; Cutone JA; Seeger JD
    Pharmacoepidemiol Drug Saf; 2007 May; 16(5):504-12. PubMed ID: 17245800
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The Association Between Second-Line Oral Antihyperglycemic Medication on Types of Dementia in Type 2 Diabetes: A Nationwide Real-World Longitudinal Study.
    Kim WJ; Noh JH; Han K; Park CY
    J Alzheimers Dis; 2021; 81(3):1263-1272. PubMed ID: 33935082
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Combination therapy using metformin or thiazolidinediones and insulin in the treatment of diabetes mellitus.
    Strowig SM; Raskin P
    Diabetes Obes Metab; 2005 Nov; 7(6):633-41. PubMed ID: 16219007
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A comparison of the effects of thiazolidinediones and metformin on metabolic control in patients with type 2 diabetes mellitus.
    Seufert J; Lübben G; Dietrich K; Bates PC
    Clin Ther; 2004 Jun; 26(6):805-18. PubMed ID: 15262452
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The impact of thiazolidinedione use on outcomes in ambulatory patients with diabetes mellitus and heart failure.
    Aguilar D; Bozkurt B; Pritchett A; Petersen NJ; Deswal A
    J Am Coll Cardiol; 2007 Jul; 50(1):32-6. PubMed ID: 17601542
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Association of diet alone, insulin, sulfonylureas, metformin, and thiazolidinediones with the severity of coronary artery disease in patients with diabetes mellitus.
    Ravipati G; Aronow WS; Ahn C; Sujata K; Saulle LN; Channamsetty V; Weiss MB
    Am J Ther; 2006; 13(5):400-3. PubMed ID: 16988534
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effects of thiazolidinedione in patients with active bladder cancer.
    Li R; Metcalfe MJ; Ferguson JE; Mokkapati S; Nogueras González GM; Dinney CP; Navai N; McConkey DJ; Sahai SK; Kamat AM
    BJU Int; 2018 Feb; 121(2):244-251. PubMed ID: 28872778
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effect of metformin in the prognosis of patients with smallcell lung cancer combined with diabetes mellitus.
    Lu H; Xie F; Huang Z; Qin J; Han N; Mao W
    Adv Clin Exp Med; 2018 Sep; 27(9):1195-1199. PubMed ID: 30016011
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Initial choice of oral glucose-lowering medication for diabetes mellitus: a patient-centered comparative effectiveness study.
    Berkowitz SA; Krumme AA; Avorn J; Brennan T; Matlin OS; Spettell CM; Pezalla EJ; Brill G; Shrank WH; Choudhry NK
    JAMA Intern Med; 2014 Dec; 174(12):1955-62. PubMed ID: 25347323
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.